Cargando…
Gonadotroph Tumors Show Subtype Differences that Might Have Implications for Therapy
Gonadotroph tumors, although frequent, are poorly studied and understood, being usually included in the larger nonfunctioning pituitary neuroendocrine tumors (PitNETs) group. Moreover, in comparison to the other types of PitNETs, no established medical treatment is currently available for gonadotrop...
Autores principales: | Ilie, Mirela Diana, Vasiljevic, Alexandre, Louvet, Camille, Jouanneau, Emmanuel, Raverot, Gérald |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7226008/ https://www.ncbi.nlm.nih.gov/pubmed/32326042 http://dx.doi.org/10.3390/cancers12041012 |
Ejemplares similares
-
Intratumoural spatial distribution of S100B + folliculostellate cells is associated with proliferation and expression of FSH and ERα in gonadotroph tumours
por: Ilie, Mirela Diana, et al.
Publicado: (2022) -
Aggressive corticotroph tumors and carcinomas
por: Lasolle, Hélène, et al.
Publicado: (2022) -
The Microenvironment of Pituitary Tumors—Biological and Therapeutic Implications
por: Ilie, Mirela Diana, et al.
Publicado: (2019) -
SST5 expression and USP8 mutation in functioning and silent corticotroph pituitary tumors
por: Castellnou, Solène, et al.
Publicado: (2020) -
OR23-04 SST5 Expression and USP8 Mutation in Functioning and Silent Corticotroph Pituitary Tumors
por: castellnou, Solene, et al.
Publicado: (2020)